IGF-1 pathway
Downstream growth signalling mediated by insulin-like growth factor 1.
Much of growth hormone's anabolic effect is mediated by IGF-1, produced largely by the liver in response to GH. IGF-1 and its analogs act on growth and tissue pathways; this axis is the downstream end of growth-hormone-axis signalling.
Peptides acting through this pathway
FAQ
What does igf-1 pathway do?
Much of growth hormone's anabolic effect is mediated by IGF-1, produced largely by the liver in response to GH. IGF-1 and its analogs act on growth and tissue pathways; this axis is the downstream end of growth-hormone-axis signalling.
Which peptides act through igf-1 pathway?
IGF 1 LR3, PEG MGF, Human Growth Hormone. They share this pathway but differ in evidence, approval, and safety.
Does this mechanism prove a peptide works?
No. Mechanistic plausibility is not proof of clinical benefit — a plausible pathway is a reason to study a compound, not evidence that it works in humans.
Mechanistic plausibility is not proof of clinical benefit. Research reference only — not medical advice.